NEW YORK (GenomeWeb News) – Simulations Plus has sold a five-year license for the newest version of its ClassPharmer software to the National Institute of Health Sciences in Japan, the company said today.
 
Japan’s NIHS will use ClassPharmer to help generate chemically relevant compound classifications, Simulations Plus said. The organization had been using an earlier version of ClassPharmer, previously sold by Bioreason, which Simulations Plus acquired last year.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Nov
05
Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.